Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community

This publication has 23 references indexed in Scilit:

• Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis
  New England Journal of Medicine, 2008
• Evaluation of Gentian cystatin C reagent on Abbott Ci8200 and calculation of glomerular filtration rate expressed in mL/min/1.73 m²from the cystatin C values in mg/L
  Scandinavian Journal of Clinical and Laboratory Investigation, 2007
• A Comparison of Three Different Methods to Evaluate Endothelium-Dependent Vasodilation in the Elderly
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2005
• Calcium, Phosphorus, Parathyroid Hormone, and Cardiovascular Disease in Hemodialysis Patients: The USRDS Waves 1, 3, and 4 Study
  Journal of the American Society of Nephrology, 2005
• Mineral Metabolism, Mortality, and Morbidity in Maintenance Hemodialysis
  Journal of the American Society of Nephrology, 2004
• FGF-23 Is a Potent Regulator of Vitamin D Metabolism and Phosphate Homeostasis
  Journal of Bone and Mineral Research, 2004
• Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers
  Kidney International, 2003
• Cardiovascular Calcifications in Uremic Patients
  Journal of the American Society of Nephrology, 2003
• Arterial Calcifications, Arterial Stiffness, and Cardiovascular Risk in End-Stage Renal Disease
  Hypertension, 2001
• Methodological aspects of the evaluation of endothelium‐dependent vasodilatation in the human forearm
  Clinical Physiology and Functional Imaging, 1998